Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$57.52 - $139.24
Next Earnings Date
May 01 2025
Next Earnings Date
May 01 2025
Latest price
Market Cap | $26.22B |
EV | $26.23B |
Shares Outstanding | 392.11M |
Beta | 1.50 |
Analyst Rating | BUY |
Analyst Target Price | $99.12 |
P/E 2025E | 33.10x |
P/Revenue 2025E | 5.69x |
Revenue | 18.10% |
EPS | 35.10% |
Operating Cash Flow | 30.80% |
Free Cash Flow | 127.90% |
Revenue | 14.80% |
EPS | 22.30% |
Operating Cash Flow | 24.10% |
Free Cash Flow | 30.40% |
Gross Margin 2025E | 64.19% |
Net Profit Margin 2025E | 17.12% |
ROE 2025E | 29.56% |
ROCE 2024 | 27.63% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
DexCom, Inc.
DXCM
Sector
Healthcare
Industry
Medical - Devices
CEO
Sayer, Kevin
Employees
10,250
Website
www.dexcom.comIPO Date
2005-04-14
Headquarters
6340 Sequence Drive, San Diego, California, 92121, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved